← Leaderboards
Ernesto V Abel-Santos
Yeshiva University
$4,966,445
Attributed
$7,132,162
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $885.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,132,162 · 4
By mechanism
R01$6,295,710 · 2
R16$437,937 · 1
R15$398,515 · 1
Top collaborators
- Steven M Firestine5 shared
- Nigel Peter Minton5 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsInfectionToxinVancomycinIntestinesClostridium DifficileProphylacticGut MicrobiotaGerminationSymptomsProphylactic TreatmentAntibioticsHospitalsReproduction SporesMicrobiotaRelapseDiarrheaGrantPublic Health RelevanceContractsCostAcquired Immunodeficiency SyndromeInfection PreventionBacteria
Grant awards (17)
Using bile salt metabolism to modulate CDI prophylaxis$715,935
R01 · FY2025 · AI · contact PI
Effects of estrus cycle stages on murine CDI severity$145,886
R16 · FY2025 · AI · contact PI
Using bile salt metabolism to modulate CDI prophylaxis$739,487
R01 · FY2024 · AI · contact PI
Effects of estrus cycle stages on murine CDI severity$145,980
R16 · FY2024 · AI · contact PI
Effects of estrus cycle stages on murine CDI severity$146,071
R16 · FY2023 · AI · contact PI
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2019 · AI · contact PI
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2018 · AI · contact PI
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2017 · AI · contact PI
Prophylaxis of Clostridium difficile infection$639,084
R01 · FY2016 · AI · contact PI
Prophylaxis of Clostridium difficile infection$692,240
R01 · FY2015 · AI · contact PI
The role of calcium-DPA in the virulence of Bacillus anthracis spores$398,515
R15 · FY2013 · AI · contact PI
Antimicrobial targets of intracellular cyclic peptides$280,661
R01 · FY2007 · AI · contact PI
Antimicrobial targets of intracellular cyclic peptides$175,851
R01 · FY2006 · AI · contact PI
Antimicrobial targets of intracellular cyclic peptides$133,200
R01 · FY2006 · AI · contact PI
Antimicrobial targets of intracellular cyclic peptides$334,000
R01 · FY2005 · AI
Antimicrobial targets of intracellular cyclic peptides$334,000
R01 · FY2004 · AI
Antimicrobial targets of intracellular cyclic peptides$334,000
R01 · FY2003 · AI